Guardant Health
419 hedge funds and large institutions have $11.3B invested in Guardant Health in 2020 Q4 according to their latest regulatory filings, with 105 funds opening new positions, 180 increasing their positions, 89 reducing their positions, and 27 closing their positions.
289% more first-time investments, than exits
New positions opened: 105 | Existing positions closed: 27
102% more repeat investments, than reductions
Existing positions increased: 180 | Existing positions reduced: 89
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
30% more call options, than puts
Call options by funds: $67.3M | Put options by funds: $51.8M
21% more funds holding
Funds holding: 346 → 419 (+73)
18% more capital invested
Capital invested by funds: $9.55B → $11.3B (+$1.71B)
1.46% more ownership
Funds ownership: 85.97% → 87.43% (+1.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$203M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$172M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$126M |
| 4 |
SIG
Senator Investment Group
New York
|
+$57.5M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$57.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$886M |
| 2 |
Morgan Stanley
New York
|
-$158M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$93.7M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$79.2M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$36.8M |
GH Hedge Fund Activity: Q4 2020 in Review
419 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q4 2020, worth a combined $11.3B — up 18% from $9.55B a quarter earlier.
Buyers outnumbered sellers: 105 funds opened new GH positions and 27 closed out — a net gain of 78 holders — while 180 added to existing stakes and 89 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $203M. The largest seller was SB Investment Advisers (UK), cutting an estimated $886M.
- 419 institutional investors held Guardant Health (GH) as of Q4 2020, up from 346 in Q3 2020.
- Funds reported $11.3B of Guardant Health stock for Q4 2020, up 18% quarter-over-quarter.
- 105 funds opened new Guardant Health positions in Q4 2020 and 27 closed out, a net change of +78 holders.
- The largest Guardant Health buyer in Q4 2020 was Fidelity Investments, an estimated $203M added.
- The largest Guardant Health seller in Q4 2020 was SB Investment Advisers (UK), an estimated $886M sold.
Based on aggregated 13F filings for Q4 2020.